Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.
Blower. Ryan J RJ; Barksdale. Stephanie M SM; van Hoek. Monique L ML
Key Findings
- LL‑37 is bactericidal against Burkholderia thailandensis, a model for highly resistant pathogens.
- LL‑37 prevents the formation of bacterial biofilms and can disperse biofilms that are already formed.
- Human alpha‑defensins (HNP‑1, HNP‑2) and a short beta‑defensin peptide showed no killing activity against this bacterium.
Practical Outcomes
- For self‑directed health optimizers, the data suggest LL‑37 has strong antimicrobial and antibiofilm activity against a resistant Gram‑negative species, but the research is limited to petri‑dish experiments. No dosing, safety, or delivery information for humans is provided, so it’s not yet ready for personal supplementation or therapeutic use without further study.
Summary
The study shows that the human antimicrobial peptide LL‑37 can kill a tough, drug‑resistant Gram‑negative bacterium (Burkholderia thailandensis) and can stop or break down the protective biofilm these bacteria make. Other similar immune peptides didn’t work, but LL‑37 (and its mirror‑image version) were effective in lab tests.
Abstract
Burkholderia thailandensis is a Gram-negative soil bacterium used as a model organism for B. pseudomallei, the causative agent of melioidosis and an organism classified category B priority pathogen and a Tier 1 select agent for its potential use as a biological weapon. Burkholderia species are reportedly "highly resistant" to antimicrobial agents, including cyclic peptide antibiotics, due to multiple resistance systems, a hypothesis we decided to test using antimicrobial (host defense) peptides. In this study, a number of cationic antimicrobial peptides (CAMPs) were tested in vitro against B. thailandensis for both antimicrobial activity and inhibition of biofilm formation. Here, we report that the Chinese cobra (Naja atra) cathelicidin NA-CATH was significantly antimicrobial against B. thailandensis. Additional cathelicidins, including the human cathelicidin LL-37, a sheep cathelicidin SMAP-29, and some smaller ATRA peptide derivatives of NA-CATH were also effective. The D-enantiomer of one small peptide (ATRA-1A) was found to be antimicrobial as well, with EC50 in the range of the L-enantiomer. Our results also demonstrate that human alpha-defensins (HNP-1 & -2) and a short beta-defensin-derived peptide (Peptide 4 of hBD-3) were not bactericidal against B. thailandensis. We also found that the cathelicidin peptides, including LL-37, NA-CATH, and SMAP-29, possessed significant ability to prevent biofilm formation of B. thailandensis. Additionally, we show that LL-37 and its D-enantiomer D-LL-37 can disperse pre-formed biofilms. These results demonstrate that although B. thailandensis is highly resistant to many antibiotics, cyclic peptide antibiotics such as polymyxin B, and defensing peptides, some antimicrobial peptides including the elapid snake cathelicidin NA-CATH exert significant antimicrobial and antibiofilm activity towards B. thailandensis.
Study Information
pubmed
2015
2015-07-21T00:00:00.000Z
10.1371/journal.pntd.0003862
46
61